EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes

Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Victoria Olinca iD, Cătălin Coroleucă iD, Diana-Elena Comandașu, Ciprian Andrei Coroleuca, Calina Maier, Elvira Bratila

Journal of Clinical Medicine · 19.02.2025 · 14 (4) · 1385

DOI: 10.3390/jcm14041385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.02.2025. Verfasst von Maria-Bianca Anca-Stanciu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries, with rising incidence due to aging populations and obesity-related factors. This review explores the evolving molecular and FIGO classifications of EC, highlighting their significance in diagnosis, prognosis, and personalized treatment strategies. Molecular subtyping based on The Cancer Genome Atlas (TCGA) classification offers a more precise understanding of EC, dividing it into POLE ultramutated, microsatellite instability-high (MSI-H), copy-number low (CNL), and copy-number high (CNH) subtypes. Each subgroup has distinct genetic, histological, and prognostic characteristics. Recent updates to the FIGO staging system incorporate molecular features, allowing for more tailored treatment approaches. Advances in immunotherapy, targeted therapies, and novel therapeutic combinations have reshaped clinical management. This review emphasizes the integration of molecular diagnostics into routine practice, outlining challenges and future perspectives in managing EC for improved patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

FIGO classificationPOLE ultramutatedThe Cancer Genome Atlas (TCGA)copy-number high (CNH)copy-number low (CNL)endometrial cancerimmunotherapymicrosatellite instability-high (MSI-H)molecular classificationpersonalized medicinetargeted therapies

Autor:innen und Institutionen

  • Department of Gynecology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Panait Sirbu Obstetrics and Gynaecology Hospital Bucharest, 060251 Bucharest, Romania.
  • Department of Morphological Sciences, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

ORCID-Profile: Maria Victoria Olinca, Cătălin Coroleucă

Zitieren

APA

Anca-Stanciu, M. B., Manu, A., Olinca, M. V., Coroleucă, C., Comandașu, D. E., Coroleuca, C. A., Maier, C., & Bratila, E. (2025). Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes. Journal of Clinical Medicine, 14(4), 1385. https://doi.org/10.3390/jcm14041385

Vancouver

Anca-Stanciu MB, Manu A, Olinca MV, Coroleucă C, Comandașu DE, Coroleuca CA, et al. Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes. Journal of Clinical Medicine. 2025;14(4):1385. doi:10.3390/jcm14041385

BibTeX
@article{AncaStanciu2025,
  author = {Anca-Stanciu, Maria-Bianca and Manu, Andrei and Olinca, Maria Victoria and Coroleucă, Cătălin and Comandașu, Diana-Elena and Coroleuca, Ciprian Andrei and Maier, Calina and Bratila, Elvira},
  title = {Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1385},
  doi = {10.3390/jcm14041385}
}
Kostenlos starten →